{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:25:00Z","timestamp":1762431900406,"version":"3.37.3"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P3-0019"],"award-info":[{"award-number":["P3-0019"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010662","name":"H2020 Excellent Science","doi-asserted-by":"publisher","award":["H2020-MSCA-ITN:721236 TREATMENT"],"award-info":[{"award-number":["H2020-MSCA-ITN:721236 TREATMENT"]}],"id":[{"id":"10.13039\/100010662","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0240754","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T18:39:57Z","timestamp":1603737597000},"page":"e0240754","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Aripiprazole reduces liver cell division"],"prefix":"10.1371","volume":"15","author":[{"given":"Tinkara","family":"Pirc Marolt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Kramar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klara","family":"Bulc Rozman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Du\u0161an","family":"\u0160uput","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6948-7238","authenticated-orcid":true,"given":"Irina","family":"Milisav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,10,26]]},"reference":[{"issue":"2","key":"pone.0240754.ref001","first-page":"53","article-title":"Aripiprazole-induced Asymptomatic Hypertension: A Case Report.","volume":"47","author":"H Seven","year":"2017","journal-title":"Psychopharmacol Bull"},{"issue":"3","key":"pone.0240754.ref002","first-page":"303","article-title":"Elevated lipase and diabetic ketoacidosis associated with aripiprazole.","volume":"7","author":"S Reddymasu","year":"2006","journal-title":"JOP"},{"issue":"2","key":"pone.0240754.ref003","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/0004867417743342","article-title":"Rhabdomyolysis and elevated liver enzymes after rapid correction of hyponatremia due to pneumonia and concurrent use of aripiprazole: A case report","volume":"52","author":"X Zhu","year":"2018","journal-title":"Aust N Z J Psychiatry"},{"issue":"2","key":"pone.0240754.ref004","doi-asserted-by":"crossref","DOI":"10.4172\/2329-6887.1000201","article-title":"Acute Drug-Induced Hepatitis during Aripiprazole Monotherapy: A Case Report","volume":"4","author":"J Kornischka","year":"2016","journal-title":"Journal of Pharmacovigilance"},{"issue":"4","key":"pone.0240754.ref005","doi-asserted-by":"crossref","first-page":"551","DOI":"10.9758\/cpn.2019.17.4.551","article-title":"Aripiprazole-induced Hepatitis: A Case Report.","volume":"17","author":"L Castanheira","year":"2019","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"1","key":"pone.0240754.ref006","doi-asserted-by":"crossref","first-page":"37","DOI":"10.31887\/DCNS.2006.8.1\/bwinklbaur","article-title":"Substance abuse in patients with schizophrenia.","volume":"8","author":"B Winklbaur","year":"2006","journal-title":"Dialogues Clin Neurosci"},{"issue":"8","key":"pone.0240754.ref007","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1176\/appi.ajp.162.8.1483","article-title":"Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress.","volume":"162","author":"KT Brady","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"19","key":"pone.0240754.ref008","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.","volume":"264","author":"DA Regier","year":"1990","journal-title":"JAMA"},{"issue":"4","key":"pone.0240754.ref009","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.jcp.0000169419.38899.5b","article-title":"Aripiprazole in schizophrenia with cocaine dependence: a pilot study.","volume":"25","author":"TP Beresford","year":"2005","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"pone.0240754.ref010","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/JCP.0000000000000789","article-title":"Late Reduction of Cocaine Cravings in a Randomized, Double-Blind Trial of Aripiprazole vs Perphenazine in Schizophrenia and Comorbid Cocaine Dependence.","volume":"37","author":"T Beresford","year":"2017","journal-title":"J Clin Psychopharmacol."},{"issue":"3","key":"pone.0240754.ref011","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00213-011-2231-6","article-title":"Aripiprazole maintenance increases smoked cocaine self-administration in humans","volume":"216","author":"M Haney","year":"2011","journal-title":"Psychopharmacology (Berl)."},{"issue":"3","key":"pone.0240754.ref012","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1037\/a0035165","article-title":"Aripiprazole effects on self-administration and pharmacodynamics of intravenous cocaine and cigarette smoking in humans.","volume":"22","author":"MR Lofwall","year":"2014","journal-title":"Exp Clin Psychopharmacol"},{"issue":"6","key":"pone.0240754.ref013","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/00952990802308262","article-title":"The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance II: increased aripipirazole dose and maintenance period","volume":"34","author":"JA Lile","year":"2008","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1","key":"pone.0240754.ref014","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/FBP.0000000000000268","article-title":"Aripiprazole for cocaine abstinence: a randomized-controlled trial with ecological momentary assessment","volume":"28","author":"LM Moran","year":"2017","journal-title":"Behav Pharmacol"},{"issue":"1","key":"pone.0240754.ref015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/jcp.0b013e3181602fd4","article-title":"A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence","volume":"28","author":"RF Anton","year":"2008","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"pone.0240754.ref016","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/acer.13417","article-title":"Aripiprazole Suppression of Drinking in a Clinical Laboratory Paradigm: Influence of Impulsivity and Self-Control","volume":"41","author":"RF Anton","year":"2017","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"pone.0240754.ref017","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/alcalc\/agx108","article-title":"Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study","volume":"53","author":"CL Haass-Koffler","year":"2018","journal-title":"Alcohol Alcohol"},{"key":"pone.0240754.ref018","unstructured":"An Study of Aripiprazole in the Treatment of Methamphetamine Dependence. 19 March 2013 [last updated 4 February 2015]. ClinicalTrials.gov. Bethesda (MD): U.S. National Library of Medicine. 2000 -. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01813656?cond=NCT01813656&draw=2&rank=1 (accssed 24 April 2020) ClinicalTrials.gov Identifier: NCT01813656. [Internet]. 2013."},{"key":"pone.0240754.ref019","unstructured":"Hao W. A Comparison of Risperidone and Aripiprazole for Treatment of Patirnts With Methamphetamine-Associated Psychosis. 19 March 2013 [last updated 4 February 2015]. ClinicalTrials.gov. Bethesda (MD): U.S. National Library of Medicine. 2000 - https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01813643?cond=NCT01813643&draw=2&rank=1 (accssed (accessed 24 April 2020) ClinicalTrials.gov Identifier: NCT01813643. 2013."},{"issue":"21","key":"pone.0240754.ref020","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMra032424","article-title":"Drug metabolism and variability among patients in drug response","volume":"352","author":"GR Wilkinson","year":"2005","journal-title":"N Engl J Med"},{"issue":"24","key":"pone.0240754.ref021","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.2174\/0929867311320240006","article-title":"Drug-induced liver injury: mechanisms, types and biomarkers","volume":"20","author":"M Vinken","year":"2013","journal-title":"Curr Med Chem"},{"issue":"5","key":"pone.0240754.ref022","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMra021844","article-title":"Drug-induced hepatotoxicity.","volume":"349","author":"WM Lee","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0240754.ref023","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL Clinical Practice Guidelines: Drug-induced liver injury.","volume":"70","author":"EASL","year":"2019","journal-title":"J Hepatol"},{"issue":"1","key":"pone.0240754.ref024","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cbi.2004.09.011","article-title":"Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential","volume":"150","author":"JJ Xu","year":"2004","journal-title":"Chem Biol Interact"},{"issue":"2","key":"pone.0240754.ref025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/0253-7613.108280","article-title":"Effect of combination of aripiprazole with carbamazepine and fluvoxamine on liver functions in experimental animals","volume":"45","author":"CS Shastry","year":"2013","journal-title":"Indian J Pharmacol"},{"issue":"1","key":"pone.0240754.ref026","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/hep.22915","article-title":"S6K1 deficiency protects against apoptosis in hepatocytes","volume":"50","author":"A Gonzalez-Rodriguez","year":"2009","journal-title":"Hepatology"},{"key":"pone.0240754.ref027","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.fct.2015.03.029","article-title":"Role of hepatocyte S6K1 in palmitic acid-induced endoplasmic reticulum stress, lipotoxicity, insulin resistance and in oleic acid-induced protection","volume":"80","author":"V Pardo","year":"2015","journal-title":"Food Chem Toxicol"},{"issue":"10","key":"pone.0240754.ref028","article-title":"Beneficial Role of ROS in Cell Survival: Moderate Increases in H2O2 Production Induced by Hepatocyte Isolation Mediate Stress Adaptation and Enhanced Survival.","volume":"8","author":"IP Miller","year":"2019","journal-title":"Antioxidants (Basel)."},{"issue":"1","key":"pone.0240754.ref029","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0304-3940(02)01423-4","article-title":"Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data.","volume":"339","author":"C Ramakers","year":"2003","journal-title":"Neurosci Lett"},{"issue":"6","key":"pone.0240754.ref030","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/gkp045","article-title":"Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data","volume":"37","author":"JM Ruijter","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"pone.0240754.ref031","first-page":"229","volume-title":"Cytochrome P450 Protocols.","author":"PV Papeleu","year":"2006","edition":"2"},{"issue":"9","key":"pone.0240754.ref032","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/sj.cdd.4401043","article-title":"Spontaneous apoptosis in primary cultures of human and rat hepatocytes: molecular mechanisms and regulation by dexamethasone","volume":"9","author":"B Bailly-Maitre","year":"2002","journal-title":"Cell Death Differ"},{"issue":"1","key":"pone.0240754.ref033","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-4827(87)90113-3","article-title":"The Fao cell. A tissue culture model for lipoprotein synthesis and secretion. II. Modulation by lipid depletion and supplementation","volume":"170","author":"ML Scarino","year":"1987","journal-title":"Exp Cell Res"},{"issue":"Pt 2","key":"pone.0240754.ref034","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1242\/jcs.104.2.307","article-title":"Non-genotoxic hepatocarcinogenesis in vitro: the FaO hepatoma line responds to peroxisome proliferators and retains the ability to undergo apoptosis","volume":"104","author":"AC Bayly","year":"1993","journal-title":"J Cell Sci"},{"key":"pone.0240754.ref035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-4939-8900-3_6","article-title":"Methodological Approach for the Evaluation of FOXO as a Positive Regulator of Antioxidant Genes.","volume":"1890","author":"M Monsalve","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"1\u201302","key":"pone.0240754.ref036","first-page":"e1","article-title":"Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.","volume":"51","author":"C Hiemke","year":"2018","journal-title":"Pharmacopsychiatry."},{"issue":"8","key":"pone.0240754.ref037","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/jclinpath-2011-200532","article-title":"Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa.","volume":"65","author":"S Gunia","year":"2012","journal-title":"J Clin Pathol"},{"issue":"4","key":"pone.0240754.ref038","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jhep.2016.05.030","article-title":"Senescence in chronic liver disease: Is the future in aging?","volume":"65","author":"AD Aravinthan","year":"2016","journal-title":"J Hepatol"},{"issue":"5","key":"pone.0240754.ref039","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2174\/156652412800619978","article-title":"GADD45 proteins: central players in tumorigenesis","volume":"12","author":"RE Tamura","year":"2012","journal-title":"Curr Mol Med"},{"issue":"1","key":"pone.0240754.ref040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/cdd.2017.174","article-title":"Mechanisms of transcriptional regulation by p53","volume":"25","author":"KD Sullivan","year":"2018","journal-title":"Cell Death Differ"},{"key":"pone.0240754.ref041","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1038\/bcj.2014.29","article-title":"The role of epigenetics in the biology of multiple myeloma","volume":"4","author":"K Dimopoulos","year":"2014","journal-title":"Blood Cancer J"},{"issue":"12","key":"pone.0240754.ref042","first-page":"4279","article-title":"The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4","volume":"5","author":"A Kubo","year":"1999","journal-title":"Clin Cancer Res"},{"issue":"2","key":"pone.0240754.ref043","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/bcpt.12902","article-title":"Overdoses with Aripiprazole: Signs, Symptoms and Outcome in 239 Exposures Reported to the Danish Poison Information Centre.","volume":"122","author":"AP Christensen","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"pone.0240754.ref044","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1574886311308030011","article-title":"Liver injury associated with antidepressants","volume":"8","author":"SH Park","year":"2013","journal-title":"Curr Drug Saf"},{"key":"pone.0240754.ref045","unstructured":"LiverTox. Clinical and Research Information on Drug Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. Carbamazepine. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548097\/ (accessed 19 March 2020) 2012 [updated 2017\/01\/152020\/03\/19]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548097\/."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0240754","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T20:45:17Z","timestamp":1669322717000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0240754"}},"subtitle":[],"editor":[{"given":"Ezio","family":"Laconi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,26]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0240754","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,10,26]]}}}